Skip to main content
  1. Right Decisions
  2. GGC - Clinical Guidelines
  3. Paediatrics
  4. Back
  5. Emergency Medicine (Paediatric)
  6. Pain management in children, paediatric emergency medicine (335)
Important: please update your RDS app to version 4.7.3 Details with newsletter below.

Please update your RDS app to v4.7.3

We asked you in January to update to v4.7.2.  After the deployment planned for 27th February, this new update will be needed to ensure that you are able to download RDS toolkits even when the RDS website is not available. We will wait until as many users as possible have downloaded the new version before switching off the old system for app downloads and moving entirely to the new approach.

To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. 

To update to the latest release:

 On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Right Decision Service newsletter: February 2025

Welcome to the February 2025 update from the RDS team

1.     Next release of RDS

 

A new release of RDS is planned (subject to outcomes of current testing) for week beginning 24th February. This will deliver:

 

  • Fixes to mitigate the recurring glitches with the RDS admin area and the occasional brief user interface outages which have arisen following implementation of the new distributed technology infrastructure in December 2024.

 

  • Capability to embed content from Google calendar, Google Maps, Daily Motion, Twitter feeds, Microsoft Stream into RDS pages.

 

  • Capability to include simple multiplication in RDS calculators.

 

The release will also incorporate a number of small fixes, including:

  • Exporting of form within Medicines Sick Day Guidance in polypharmacy toolkit
  • Links to redundant content appearing in search in some RDS toolkits
  • Inclusion of accordion headers alongside accordion text in search result snippets.
  • Feedback form on mobile app.
  • Internal links on mobile app version of benzo tapering tool

 

We will let you know when the date and time for the new release are confirmed.

 

2.     New RDS developments

There is now the capability to publish toolkits on the web with left hand side navigation rather than tiles on the homepage. To use this feature, turn on the “Toggle navigation panel” option at the top of the Page settings menu at toolkit homepage level – see below. Please note that publication to downloadable mobile app for this type of navigation is still under development.

The Benzodiazepine tapering tool (https://rightdecisions.scot.nhs.uk/benzotapering) is now available as part of the RDS toolkit for the national benzodiazepine prescribing guidance developed by the Scottish Government Effective Prescribing team. The tool uses this national guidance developed with a wide-ranging multidisciplinary group. This should be used in combination with professional judgement and an understanding of the needs of the individual patient.

3.     Archiving and version control and new RDS Search and Browse interface

Due to the intensive work Tactuum has had to undertake on the new technology infrastructure has pushed back the delivery dates again and some new requirements have come out of the recent user acceptance testing. It now looks likely to be an April release for the search and browse interface. The archiving and version control functionality may be released earlier. We’ll keep you posted.

4.     Statistics

At the end of January, Olivia completed the generation of the latest set of usage statistics for all RDS toolkits. If you would like a copy of the stats for your toolkit, please contact Olivia.graham@nhs.scot .

 

5.     Review of content past its review date

We have now generated reports of all RDS toolkit content that has exceeded its review date by 6 months or more. We will be in touch later this month with toolkit owners and editors to agree the plan for updating or withdrawing out of date content.

 

6.     Toolkits in development

Some important toolkits in development by the RDS team include:

  • National CVD prevention pathways – due for release end of March 2025.
  • National respiratory pathways, optimal cancer diagnostic pathways and cancer prehabilitation pathways from the Centre for Sustainable Delivery. We will shortly start work on the national cancer referral pathways, first version due for release via RDS around end of June 2025.
  • HIS Quality of Care Review toolkit – currently in final stages of quality assurance.

 

The RDS team and other information scientists in HIS have also been producing evidence summaries for the Scottish Government Realistic Medicine team, to inform development of national guidance around Procedures of Limited Clinical Value. This guidance will in due course be translated into an RDS toolkit.

 

7. Training sessions for new editors (also serve as refresher sessions for existing editors) will take place on the following dates:

  • Friday 28th February 12-1 pm
  • Tuesday 11th March 4-5 pm

 

To book a place, please contact Olivia.graham@nhs.scot, providing your name, organisation, job role, and level of experience with RDS editing (none, a little, moderate, extensive.)

 

To invite colleagues to sign up to receive this newsletter, please signpost them to the registration form  - also available in End-user and Provider sections of the RDS Learning and Support area.   If you have any questions about the content of this newsletter, please contact his.decisionsupport@nhs.scot  If you would prefer not to receive future newsletters, please email Olivia.graham@nhs.scot and ask to be removed from the circulation list.

With kind regards

 

Right Decision Service team

Healthcare Improvement Scotland

 

 

Pain management in children, paediatric emergency medicine (335)

Warning

Objectives

  • Recognise pain in children and provide analgesia for moderate & severe pain within 20 minutes of arrival in the Emergency Department
  • In treating pain, attention should be paid to other factors distressing the child such as fear of unfamiliar environment and people, parental distress, people in uniforms, needle avoidance, fear of injury severity etc.

Scope

Patients presenting to the Paediatric Emergency Department. 

Audience

Medical and nursing staff in the Paediatric Emergency Department.

November 2023: This guidance is currently under review as it has gone beyond the standard review date. It reflects best practice at the time of authorship / last review and remains safe for use. If there are any concerns regarding the content then please consult with senior clinical staff to confirm.

Introduction

Pain in children can be difficult to assess (for example the child may not appear distressed or have difficulty describing / admitting to pain). This can lead to pain being under-recognised, under-treated and treatment being delayed. Drug choice and dosage may also cause problems in those not used to treating children due to unfamiliarity.

Pain assessment

  • Pain assessment should be repeated frequently to ensure adequate response to any intervention.
  • In the Emergency Department of the Royal Hospital for Sick Children, it is the experience of the Triage Nurse that is used to gauge the severity of a child’s pain, based on their observation and feedback from parents.

For example:

  No Pain Mild Pain Moderate Pain Severe Pain
Behaviour Normal activity 
No↓ in movement 
Happy
Rubbing affected area 
Decreased movement 
Neutral expression 
Able to talk/play normally
Protective of affected area 
↓movement / quiet 
Complaining of pain 
Consolable crying 
Grimaces when affected part moved / touched
No movement or defensive of affected part 
Looking frightened 
Very quiet
Restless, unsettled 
Complaining of lots of pain Inconsolable crying
Injury example*   Abrasion / small laceration Ankle sprain 
Minor head injury
Small burn / scald 
Undisplaced limb #
Fingertip injury 
Appendicitis
Displaced limb # # dislocation 
Larger burns/scalds Appendicitis 
Sickle crisis

* Example of injury is only intended as a guide – cases should be assessed on an individual basis

Algorithm for treatment of acute pain in children in the Emergency Department

Pain assessment algorithm

If child is being admitted and is likely to need ongoing analgesia for moderate / severe pain, consider contacting pain relief nurse specialist (page 8133/ ext. 86920) or duty anaesthetist (page 8602).

Other ways to manage pain

  • Psychological strategies: involving parents, cuddles, child-friendly environment, and explanation with reassurance all help build trust. Also, distraction with toys, blowing bubbles, reading, portable DVD players or story-telling can help to alleviate pain.
  • Non-pharmacological adjuncts such as limb immobilisation for fractures and dressings for burns.

Guideline for using intranasal FENTANYL in the Emergency Department

- to be used in conjunction with Emergency Department Pain Management guideline

Indications:

To be included as part of the first-line treatment of severe pain in a child (without IV access). 
For example, in children with pain secondary to:
 - Clinically suspected limb fractures
 - Painful/distressing burns

Contraindications:

  • Need for immediate IV access (use parenteral morphine)
  • Significant nasal trauma
  • Blocked nose or upper respiratory tract infection
  • Age < 1 year (or weight < 10kg)
  • General contraindications/sensitivity to fentanyl or other opioid use
  • Significant head injury
  • MAOI anti-depressant within 14 days

Adverse Effects:

  • Adverse effects are uncommon, but may include:
  • Respiratory depression
  • Hypotension
  • Nausea and vomiting
  • Itch
  • Chest wall rigidity (only reported in rapid large IV doses)

Protocol:

  1. Weigh the child in kg, attach monitor for continuous O2 saturations
  2. Draw up calculated dose of Fentanyl according to weight
  3. Attach atomiser (MAD device WolfeTory ®) to the 1ml syringe (if total calculated dose over 1ml then draw up additional dose volume in another 1ml syringe)
  4. Position patient either sitting up at 45° or with head to one side
  5. Administer dose by inserting into nostril loosely and aim for centre of nasal cavity prior to squirting
  6. If the dose is > 0.6mL, split dose between both nostrils to prevent loss of solution by sneezing or swallowing.
  7. Depress the plunger quickly
  8. Hold atomiser in place for further 5 seconds to prevent medication from dribbling out of nostril
  9. Don’t forget to give supplementary oral analgesia (if not contra-indicated) and that the child may need ongoing IV analgesia once the initial pain is controlled
  10. Continue 02 sats monitoring for at least 1 hour post administration
  11. Therapeutic levels are reached within 2 minutes and may last for up to 30 minutes. The dose can be repeated after 30 minutes if adequate analgesia is not achieved after the first dose.

Intranasal FENTANYL guideline for dosing and administration

Dose = approximately 1.5 micrograms/kg (repeat after 30mins if needed)

Preparation: Fentanyl injection 50 micrograms in 1ml (CD) (dilution not required)

Weight of child (kg)

Dose (micrograms)
(rounded to nearest whole number)

Dose volume (to 1 decimal place)

10

15

0.3 ml

13

20

0.4 ml

15

25

0.5 ml

20

30

0.6 ml

25

40

0.8 ml

30

45

0.9 ml

35

55

1.1 ml

40

60

1.2 ml

45

70

1.4 ml

50

75

1.5 ml

55

85 

1.7 ml

60

90

1.8 ml

Approved by RHC ED Consultant group with approval from RHC Drugs and Therapeutics Committee pending: February 2022

Editorial Information

Last reviewed: 09/02/2022

Next review date: 30/04/2024

Author(s): Dr Joanne Stirling (Consultant in Paediatric Emergency Medicine, RHCG), Correspondence author - Dr Steve Foster (Consultant in Paediatric Emergency Medicine, RHCG).

Version: 3

Approved By: Paediatric Drugs and Therapeutics Committee, RHCG. RHC ED clinical governance group, RHCG

Document Id: 335